Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ANXA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PKP3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HMG20A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TMX2-CTNND1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CCNG2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PGPEP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ATP6V0E1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FTH1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CRADD - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR6831 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
POLR1C - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CRYAA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TGFBI - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
STIP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC35E1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
COQ4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PCNX2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WDFY3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TAB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on